Analysis of Kidney Function Tests as Predictor of Mortality in COVID-19
DOI:
https://doi.org/10.24293/ijcpml.v29i2.1985Keywords:
Urea, creatinine, glomerular filtration rate, a predictor of COVID-19Abstract
Cytokine release syndrome and Acute Respiratory Distress Syndrome (ARDS) increase the incidence of Acute Kidney Injury (AKI) in COVID-19 patients, which is associated with a poor prognosis and risk of death. The purpose of this study was to analyze urea, creatinine, and eGFR values as predictors of mortality in COVID-19 patients. A retrospective cohort study was carried out using secondary data from medical records of 311 COVID-19 patients who were treated at the Hasanuddin University State Higher Education Hospital from August 2020 to August 2021. Data were analyzed using the Mann-Whitney test, Chi-Square, and Logistic Regression. The risk of mortality for COVID-19 patients with urea levels > 53 mg/dL was 5.128 times higher than that of urea levels ‰ 53 mg/dL (OR=5.128; CI =2.530 – 10.391, p<0.001). The risk of mortality for COVID-19 patients with creatinine levels > 1.3 mg/dL was 2.696 times higher than that of creatinine levels ‰ 1.3 mg/dL (OR= 2.696; CI = 1.330 – 5.463, p<0.001). The risk of mortality in COVID-19 patients with an eGFR < 90 mL/min/1.73 m2 was 3.692 times higher than that of an eGFR ‰ 90 mL/min/1.73 m2 (OR=3.692; CI = 2.134 – 6.389, p<0.001). Multiple logistic regression analysis showed that urea and eGFR were better predictors of mortality than creatinine (OR= 0.374, p=0.002 vs. OR 0.344, p=0.007 vs. OR 1.192, p=0.694). The COVID-19 patient group with high serum urea and creatinine levels and low eGFR values had a greater risk of mortality compared to the group of patients who had normal results. Urea levels and eGFR values were better predictors of mortality than serum creatinine.
Downloads
References
Kemenrerian Kesehatan. Pedoman pencegahan dan pengendalian Coronavirus Diseases (COVID-19). Jakarta, Kementrian Kesehat, 2020; 5: 178.
Susilo A, Cleopas Martin Rumende, Ceva Wicaksono Pitoyo, Djoko Widayat, Mira Yulianti, et al. Coronavirus disease 2019: Tinjauan literatur terkini Coronavirus disease 2019: Review of current literatures. J. Penyakit Dalam Indones, 2020; 7: 45–67.
Zhu N, Zhang D, Wang W, Li X, Bo Yang, et al. A novel Coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med, 2020; 382: 727–733.
Riedel S, Morse S, Mietzner T, MS. Jawetz, Melnick, Adelberg's. Medical microbiology, US, McGraw- Hill Education/Medical, 2019; 1-12.
Burhan E, Susanto AD, Nasution AS, Ginanjar E, Pitoyo CW, et al. Protokol pelaksanaan COVID-19. 1st Ed., Jakarta, PDPI, PERKI, PAPDI, IDAI, PERDATIN, 2020; 1–50.
Kemenkes. Pedoman kesiapan menghadapi COVID-19. 2020; 1-89.
Rothan HA, Byraredd SN, Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of Coronavirus Disease (COVID-19) outbreak. J. Autoimmun, 2020; 109: 102433.
WHO. WHO Coronavirus (COVID-19) dashboard global Situation. WHO, 2021 1-4.
Liu Q, Wang Y, Zhao X, Wang L, Liu F, et al. Diagnostic performance of a blood urea nitrogen to creatinine ratio-based nomogram for predicting in-hospital mortality in COVID-19 patients. Risk Manag. Healthc. Policy, 2021; 14: 117–128.
Wu T, Zuo Z, Kang S, Jiang L, Luo X, et al. Multi-organ dysfunction in patients with COVID-19: A systematic review and meta-analysis. Aging Dis, 2020; 11: 874–894.
Mudatsir M, Jonny Karunia Fajar, Laksmi Wulandari, Gatot Soegiarto, Muhammad Ilmawan, et al. Predictors of COVID-19 severity: A systematic review and meta-analysis. F1000Research, 2020; 1–24.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. 2020. Available from: medRxiv at https://doi.org/10.1101/2020.02.18.20023242 (accessed August 3, 2021).
Nogueira SÁR, Oliveira SCS, Carvalo AFM, Neves JMC, Silva LSV, et al. Renal changes and acute kidney injury in COVID-19: A systematic review. Rev. Assoc. Med. Bras, 2020; 66(2): 112-117.
Mukherjee S, Pahan K. Is COVID-19 Gender-sensitive?. J. Neuroimmune Pharmacol, 2021; 16(1): 38-47.
Guan Wei-ji, Ni Zheng-yi, Yu Hu, Liang Wen-hua, Ou Chun-quan, et al. Clinical characteristics of Coronavirus disease 2019 in China. N. Engl. J. Med, 2020; 382: 1708–1720.
Surendra H, Iqbal Rf Elyazar, Bimandra A Djaafara, Lenny L Ekawati, kartika Saraswati, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg. Heal. - West. Pacific, 2021; 9: 100108.
Anonim. Data pantauan COVID-19 di Sulawesi Selatan. (2021). Available at https://covid19.sulselprov.go.id/. (accessed July 22, 2021).
Liu S, Jiang L, Li Xi, Lin F, Wang Y, et al. Clinical and pathological investigation of patients with severe COVID-19. JCI Insight 2020; 5.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International, 2020; 97(5): 829-838.
Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol, 2021; 93(2): 786-793.
Gameiro J, Fonseca JA, Jorge S and Lopes JA. Acute kidney injury definition and diagnosis: A narrative review. Journal of Clinical Medicine, 2018; 7(10); 1-13.
Melyda. Diagnosis dan tatalaksana Acute Kidney Injury (AKI) pada syok septik. CDK, 2017; 259(44): 907–911.
Michael B, Vikse J, Benoit S, Favaloro EJ. Hyperinflammation and derangement of the renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hyper coagulopathy and microvascular immunothrombosis. Clin. Chim. Acta, 2020; 507: 167–173.
Kai H, Kai M. Interactions of Coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens. Res, 2020; 43: 648–654.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
